Development of Adoptive immunotherapy of EBV-associated Malignancies by Retroviral LMP2-TCR Gene Transfer
Development of Adoptive immunotherapy of EBV-associated Malignancies by Retroviral LMP2-TCR Gene Transfer
通过逆转录病毒 LMP2-TCR 基因转移开发 EBV 相关恶性肿瘤的过继免疫疗法
批准号：
G0902209/1
负责人：
Hans Stauss
金额：
$35.45万
依托单位国家：
英国
项目类别：
Research Grant
财政年份：
2010
资助国家：
英国
项目状态：
已结题
起止时间：
2010 至 --
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Epstein Barr Virus (EBV) can cause several different types of cancer. There are currently no treatments available for some of these cancers. Our proposal is to take blood cells from patients with EBV-associated cancer and turn them into killer cells directed towards the cancer cells and then inject back into the patient. These killer cells will then be able to destroy the cancer cells and cure the patient.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antigen-specific co-stimulation to enhance the anti-tumour activity of TCR gene modified cytotoxic T lymphocytes
-
批准号：G0700149/1
-
项目类别：Research Grant
-
资助金额：$42.95万
-
财政年份：2008
-
负责人：Hans Stauss
-
依托单位：
海外基金
